SCHEMBL85837

SCHEMBL85837

C=C1CCOC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8819951 0.84
SCHEMBL459707 0.74
SCHEMBL4384324 0.74
Propiolactone SCHEMBL18277487 0.72
SCHEMBL13324555 0.72 TSHR (0.85)
SCHEMBL12158580 0.72 LMNA (0.50)
SCHEMBL19638419 0.72 TSHR (0.85)
SCHEMBL181525 0.72
Propiolactone SCHEMBL17977 0.71
Propiolactone SCHEMBL10680620 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4296365-B1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID VISOLIS INC (US) 2026-04-15 EP disclosed
US-20240218117-A1 POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES Visolis, Inc. 2024-07-04 US disclosed
EP-4296365-A2 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID Visolis, Inc. (US) 2023-12-27 EP disclosed
EP-3224368-B1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID VISOLIS INC (US) 2023-10-25 EP disclosed
EP-3224368-B1 PROCESSES FOR CONVERSION OF BIOLOGICALLY DERIVED MEVALONIC ACID VISOLIS INC (US) 2023-10-25 EP disclosed
CN-111491935-B Novel analogs as modulators of androgen and glucocorticoid receptors 昂科斯特拉公司 2023-08-22 CN disclosed
CN-112876378-B Polymers prepared from mevalonic lactones and derivatives 维索利斯有限公司 2023-08-15 CN disclosed
CN-112279744-B Method for the conversion of biologically derived mevalonate 维索利斯有限公司 2023-08-15 CN disclosed
US-11492339-B2 Processes for conversion of biologically derived mevalonic acid Visolis, Inc. (US) 2022-11-08 US disclosed
CN-107002104-B Method for conversion of biologically derived mevalonate 维索利斯有限公司 2021-08-17 CN disclosed
US-20110272097-A1 PLASMA PROCESSING APPARATUS AND METHOD KOSHIISHI AKIRA 2011-11-10 US disclosed
US-7988816-B2 Plasma processing apparatus and method TOKYO ELECTRON LIMITED (JP) 2011-08-02 US disclosed
US-7988816-B2 Plasma processing apparatus and method TOKYO ELECTRON LIMITED (JP) 2011-08-02 US disclosed
US-7740737-B2 Plasma processing apparatus and method TOKYO ELECTRON LIMITED (JP) 2010-06-22 US disclosed
US-7740737-B2 Plasma processing apparatus and method TOKYO ELECTRON LIMITED (JP) 2010-06-22 US disclosed
US-20070165355-A1 PLASMA ETCHING METHOD AND COMPUTER-READABLE STORAGE MEDIUM TOKYO ELECTON LIMITED (JP) 2007-07-19 US disclosed
US-20070165355-A1 PLASMA ETCHING METHOD AND COMPUTER-READABLE STORAGE MEDIUM TOKYO ELECTON LIMITED (JP) 2007-07-19 US disclosed
EP-1598350-B1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis SERVIER LAB (FR) 2007-07-11 EP disclosed
EP-1780777-A1 PLASMA PROCESSING DEVICE AMD METHOD Tokyo Electron Ltd. (JP) 2007-05-02 EP disclosed
EP-1598350-A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis LES LABORATOIRES SERVIER (FR) 2005-11-23 EP disclosed